| Medical and Health Sciences | Lifetime | 514 | CH 4 | 99.98 |
| Infectious Diseases | Lifetime | 14 | CH 1 | 99.94 |
| Emergency Medical Services | Lifetime | 22 | CH 1 | 99.67 |
| Critical Care and Intensive Care Medicine | Lifetime | 18 | CH 1 | 99.60 |
| Applied Microbiology and Biotechnology | Lifetime | 8 | CH 1 | 99.42 |
| Epidemiology | Lifetime | 711 | CH 6 | 99.08 |
| Clinical Biochemistry | Lifetime | 78 | CH 2 | 98.37 |
| Medical Laboratory Technology | Lifetime | 45 | CH 1 | 97.89 |
| Emergency Medicine | Lifetime | 448 | CH 3 | 95.98 |
| Microbiology | Lifetime | 597 | CH 11 | 83.42 |
| Infectious Diseases | 2021-2025 | 184 | CH 1 | 96.83 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 949 | CH 15 | 86.93 |
| Infection Control and Ventilation | Lifetime | 1 | CH 1 | 99.90 |
| Infection Control in Healthcare | Lifetime | 1 | CH 1 | 99.95 |
| Antibiotic Use and Resistance | Lifetime | 7 | CH 1 | 99.90 |
| Food Safety and Hygiene | Lifetime | 4 | CH 1 | 99.82 |
| Nosocomial Infections in ICU | Lifetime | 5 | CH 1 | 99.92 |
| Surgical site infection prevention | Lifetime | 11 | CH 1 | 99.48 |
| Bacterial Identification and Susceptibility Testing | Lifetime | 30 | CH 1 | 99.73 |
| Medical Device Sterilization and Disinfection | Lifetime | 3 | CH 1 | 99.54 |
| Antimicrobial Resistance in Staphylococcus | Lifetime | 48 | CH 1 | 99.66 |
| Central Venous Catheters and Hemodialysis | Lifetime | 68 | CH 1 | 99.30 |
| Sepsis Diagnosis and Treatment | Lifetime | 123 | CH 5 | 99.34 |
| Patient Safety and Medication Errors | Lifetime | 44 | CH 1 | 99.10 |
| Emergency and Acute Care Studies | Lifetime | 181 | CH 3 | 98.73 |
| Streptococcal Infections and Treatments | Lifetime | 165 | CH 2 | 98.82 |
| Patient Satisfaction in Healthcare | Lifetime | 93 | CH 2 | 98.70 |
| Dental Research and COVID-19 | Lifetime | 151 | CH 11 | 98.80 |
| COVID-19 and healthcare impacts | Lifetime | 429 | CH 5 | 95.00 |
| Antifungal resistance and susceptibility | Lifetime | 436 | CH 6 | 97.67 |
| Vaccine Coverage and Hesitancy | Lifetime | 468 | CH 17 | 96.94 |
| Clostridium difficile and Clostridium perfringens research | Lifetime | 522 | CH 6 | 96.45 |
| Healthcare cost, quality, practices | Lifetime | 477 | CH 6 | 94.48 |
| Workplace Violence and Bullying | Lifetime | 184 | CH 3 | 94.07 |
| Disaster Response and Management | Lifetime | 875 | CH 15 | 92.66 |
| Burn Injury Management and Outcomes | Lifetime | 402 | CH 7 | 93.41 |
| Healthcare Decision-Making and Restraints | Lifetime | 865 | CH 23 | 88.64 |
| Quality and Safety in Healthcare | Lifetime | 855 | CH 4 | 82.38 |
| Travel-related health issues | Lifetime | 923 | CH 43 | 78.43 |
| Infection Control in Healthcare | 2021-2025 | 2 | CH 1 | 99.04 |
| COVID-19 and healthcare impacts | 2021-2025 | 372 | CH 4 | 94.02 |
| Infection Control and Ventilation | 2021-2025 | 80 | CH 1 | 95.56 |
| Dental Research and COVID-19 | 2021-2025 | 239 | CH 10 | 93.58 |
| Antibiotic Use and Resistance | 2021-2025 | 710 | CH 23 | 88.25 |
| Medical Device Sterilization and Disinfection | 2021-2025 | 60 | CH 2 | 79.58 |
| Food Safety and Hygiene | 2021-2025 | 233 | CH 5 | 81.82 |
| Burn Injury Management and Outcomes | 2021-2025 | 738 | CH 16 | 60.67 |
